Insiders · DFTX

Mark Sullivan

Chief Legal Officer at Definium Therapeutics, Inc. (DFTX) since April 2023

Mark Sullivan has filed 30 insider reports with the SEC since February 2021, as chief Legal Officer at Definium Therapeutics, Inc. (DFTX), officer at Mind Medicine (MindMed) Inc. (MNMD) and officer at Sesen Bio, Inc. (CARM). In the last 12 months Mark Sullivan sold $1.45M of stock on the open market. In the latest filing, on September 30, 2026, Mark Sullivan sold 14,051 shares of Definium Therapeutics, Inc. (DFTX) for $514K at an average of $36.57.

Filings
30
Companies
3
Bought on market
None
Sold on market
$1.89M

Companies where Mark Sullivan is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Definium Therapeutics, Inc. logo
DFTX
Definium Therapeutics, Inc.
Chief Legal Officersince April 2023494,228$1.87M$29.38Sep 30, 2026
Mind Medicine (MindMed) Inc. logo
MNMD
Mind Medicine (MindMed) Inc.
OfficerDec 29, 2025
Sesen Bio, Inc. logo
CARM
Sesen Bio, Inc.
Officer299,694$23.4KFeb 24, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Mark Sullivan.

Compare Mark Sullivan with

Other insiders at the same companies

Questions about Mark Sullivan

What is Mark Sullivan's role at Definium Therapeutics, Inc.?
Mark Sullivan reports to the SEC as chief Legal Officer at Definium Therapeutics, Inc. (DFTX), according to the latest filing on September 30, 2026. Mark Sullivan has also filed as officer at Mind Medicine (MindMed) Inc. (MNMD) and officer at Sesen Bio, Inc. (CARM).
How many shares does Mark Sullivan own?
After the latest filing that states it, Mark Sullivan directly owned 494,228 shares of Definium Therapeutics, Inc. (DFTX) and 299,694 shares of Sesen Bio, Inc. (CARM). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Sullivan bought or sold stock recently?
The most recent open-market sale was on September 25, 2026: sold 14,051 shares of Definium Therapeutics, Inc. (DFTX) for $514K at an average of $36.57.
How do I get alerts when Mark Sullivan files?
Follow Mark Sullivan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Sullivan filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark Sullivan (SEC CIK 0001331843). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR